Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- Resource Type
- Article
- Source
- The Lancet HIV; August 2021, Vol. 8 Issue: 8 pe474-e485, 12p
- Subject
- Language
- ISSN
- 24054704; 23523018